HKU Scholars Hub: Browsing DSpace

Browsing by Author Chung, HC

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 7 of 7

	Title	Author(s)	Issue Date	Views
	Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens Journal:Breast Cancer Res Treat	Dai, MS Feng, YH Chen, SW Masuda, N Yau, TCC Chen, ST Lu, YS Yap, YS Ang, PCS Chu, SC Kwong, A Lee, KS Ow, S Kim, SB Lin, J Chung, HC Ngan, R Kok, VC Rau, KM Sangai, T Ng, TY Tseng, LM Bryce, R Bebchuk, J Chen, MC Hou, MF	2021
	Characterization of cues from natural multi-species biofilms that induce larval attachment of the polychaete Hydroides elegans Journal:Aquatic Biology	Hung, OS Lee, OO Thiyagarajan, V He, HP Xu, Y Chung, HC Qiu, JW Qian, PY	2008	89
	Interim report for a phase II, multi-centre, dose-escalating study of LB80380/ANA380 in hepatitis B patients with lamivudine-resistant YMDD mutant HBV Proceeding/Conference:Journal of Hepatology	Lai, CL Han, KH Yoon, SK UM, SH Yuen, MF Kim, HS Kim, HR Chung, HC Kim, CR Hsyu, P Averett, D Kim, J	2005	60
	Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial Journal:The Lancet	Shitara, K Ozguroglu, M Bang, Y-J Bartolmeo, MD Mandala, M Ryu, M-H Fornaro, L Olesinski, T Caglevic, C Chung, HC Muro, K Goekkurt, E Mansoor, W McDermott, RS Shacham-Shumueli, E Chen, X Mayo, C Kang, SP Ohtsu, A Fuchs, CS KEYNOTE-061 investigators Lam, KO	2018
	Phase II multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV Proceeding/Conference:Journal of Hepatology	Lai, CL Han, KH Yoon, SK Um, SH Yuen, MF Kim, HS Kim, HR Chung, HC Kim, CR Hsyu, P Averett, D Worland, S Kim, J	2006	148
	Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study Journal:European Journal of Cancer	Chau, I Peck-Radosavljevic, M Borg, C Malfertheiner, P Seitz, JF Park, JO Ryoo, BY Yen, CJ Kudo, M Poon, RTP Pastorelli, D Blanc, JF Chung, HC Baron, AD Okusaka, T Bowman, L Cui, ZL Girvan, AC Abada, PB Yang, L Zhu, AX	2017	9
	Statutory rights and de facto constitutional supremacy in Hong Kong? Proceeding/Conference:International Journal of Constitutional Law	Yap, PJ Chung, HC	2019	46

Showing results 1 to 7 of 7